Postpartum‐onset obsessive–compulsive disorder: A harbinger of bipolar disorder

Sharma, Verinder; Al-Farayedhi, Malak

doi:10.1111/bdi.13303

Cited by 2 publications

(2 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It classifies bipolar disorder into categories, including bipolar I disorder, bipolar II disorder, cyclothymic disorder, other specified bipolar and related disorders, and bipolar or related disorders, unspecified. 7 …”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Global perspectives on bipolar disorder treatment: in-depth comparative analysis of international guidelines for medication selection

Park,

Fernando,

Park

et al. 2024

BJPsych open

View full text Add to dashboard Cite

Background Bipolar disorder, a chronic mental health condition characterised by fluctuations in mood, energy and functionality, affects millions of individuals worldwide. Its management requires a comprehensive approach, and, as such, treatment guidelines have a pivotal role in guiding clinicians to alleviate symptoms, prevent relapse and enhance overall patient well-being. However, the treatment landscape is far from homogenous, with significant variations existing across different countries. Aims This study aimed to explore and compare treatment guidelines for bipolar disorder in various regions, shedding light on the factors that influence therapeutic approaches and thus offering insights that could contribute to the ongoing refinement of evidence-based practices in management. Method The study explores various international treatment guidelines for bipolar disorder that have been updated after 2014. Guidelines from the UK, Canada, Australia/New Zealand, South Korea and the International College of Neuropsychopharmacology are scrutinised to identify factors contributing to the observed differences among them. Results The variations in recommended drugs across guidelines arise from the approaches employed in guideline development – whether relying on expert consensus or meta-analysis results. Timing disparities in conducting these analyses and the selection of studies also exert influence. Moreover, differences in metabolic enzymes among diverse races and the health policies implemented by individual nations play a significant part in shaping these differences. Conclusion The primary hindrance to consistent treatment conclusions lies in the scarcity of high-quality research results, leading to variations in guidelines. Enhancing evidence-based recommendations necessitates the undertaking of large-scale studies dedicated to assessing treatments for bipolar disorder.

show abstract

Section: Resultsmentioning

confidence: 99%

“… 6 Continuous reassessment and treatment modifications are often necessary for the ongoing, long-term care of individuals with bipolar disorder. 7 …”

mentioning

confidence: 99%